GB201316666D0 - Targeting molecule - Google Patents

Targeting molecule

Info

Publication number
GB201316666D0
GB201316666D0 GBGB1316666.5A GB201316666A GB201316666D0 GB 201316666 D0 GB201316666 D0 GB 201316666D0 GB 201316666 A GB201316666 A GB 201316666A GB 201316666 D0 GB201316666 D0 GB 201316666D0
Authority
GB
United Kingdom
Prior art keywords
targeting molecule
targeting
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1316666.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary University of London filed Critical Queen Mary University of London
Priority to GBGB1316666.5A priority Critical patent/GB201316666D0/en
Publication of GB201316666D0 publication Critical patent/GB201316666D0/en
Priority to PCT/GB2014/052856 priority patent/WO2015040415A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
GBGB1316666.5A 2013-09-19 2013-09-19 Targeting molecule Ceased GB201316666D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1316666.5A GB201316666D0 (en) 2013-09-19 2013-09-19 Targeting molecule
PCT/GB2014/052856 WO2015040415A1 (en) 2013-09-19 2014-09-19 Targeting molecule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1316666.5A GB201316666D0 (en) 2013-09-19 2013-09-19 Targeting molecule

Publications (1)

Publication Number Publication Date
GB201316666D0 true GB201316666D0 (en) 2013-11-06

Family

ID=49553102

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1316666.5A Ceased GB201316666D0 (en) 2013-09-19 2013-09-19 Targeting molecule

Country Status (2)

Country Link
GB (1) GB201316666D0 (en)
WO (1) WO2015040415A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108484781B (en) * 2018-04-23 2021-05-04 深圳市国创纳米抗体技术有限公司 Fusion protein of nano antibody and pseudomonas aeruginosa exotoxin and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008076939A2 (en) * 2006-12-14 2008-06-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human cancer therapy using engineered matrix metalloproteinase-activated anthrax lethal toxin that targets tumor vasculature

Also Published As

Publication number Publication date
WO2015040415A1 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
IL244816A0 (en) Protein-polymer-drug conjugates
HRP20181709T1 (en) Pyridinylimidazolones as herbicides
IL245009A0 (en) Protein-polymer-drug conjugates
GB201317928D0 (en) Molecule
EP2987125A4 (en) Linked advertisements
EP2970511A4 (en) Insulin-incretin conjugates
SG11201605260VA (en) Var2csa-drug conjugates
EP2968381A4 (en) Sugar-linker-drug conjugates
GB201308917D0 (en) Delivery
EP2958889A4 (en) Neoseptins: small molecule adjuvants
GB201303405D0 (en) Chelator Molecule
AU353575S (en) Stamphousing
GB201316666D0 (en) Targeting molecule
GB201315788D0 (en) Molecule
GB201316676D0 (en) Intermediate mediums
GB201302208D0 (en) Ad match
GB201308035D0 (en) Delivery
GB201317911D0 (en) E e e
AU353325S (en) Kettlebell
AU353331S (en) Kettlebell
AU353330S (en) Kettlebell
AU353329S (en) Kettlebell
AU353328S (en) Kettlebell
AU353327S (en) Kettlebell
AU353326S (en) Kettlebell

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)